| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V129308 | Aprutumab ixadotin | 1708947-48-1 | Aprutumab ixadotin is the first antibody-drug conjugate (ADC) targeting FGFR2, and also the first ADC to use an Auristatin-based payload. |
|
V2693 | BLU-554(BLU-554) | 1707289-21-1 | BLU-554 is a novel potent, highly-selective, and orally bioavailable inhibitor of FGFR4 (fibroblast growth factor receptor 4) with an IC50 value of 5 nM in cell free assays. |
|
V0617 | BLU9931 | 1538604-68-0 | BLU9931 (BLU-9931; BLU 9931) is an irreversible and selective FGFR4 inhibitor with potential anticancer activity. |
|
V69468 | CPL304110 | 1627826-19-0 | CPL304110 is a potent, orally bioavailable, and selective inhibitor of the fibroblast growth factor receptor FGFR (1-3) with IC50s of 0.75 nM, 0.5 nM, and 3.05 nM for FGFR (1-3). |
|
V69485 | Efruxifermin | 2375240-92-7 | Efruxifermin is an Fc-FGF21 fusion protein (human IgG1 Fc domain linked to modified human FGF21). |
|
V0616 | Fexagratinib (AZD-4547; ADSK-091) | 1035270-39-3 | AZD4547 (AZD-4547; AZD 4547) is a novel and orally bioavailable FGFR (fibroblast growth factor receptor) inhibitor with potential antineoplastic activity. |
|
V118276 | FGFR-IN-23 | FGFR-IN-23 (compound 9p) is a covalent pan-FGFR inhibitor with IC50 values of 14 nM, 4.2 nM, 5 nM and 220 nM for FGFR1, FGFR2, FGFR3 and FGFR4, respectively. | |
|
V135928 | FGFR-IN-26 | 2823290-68-0 | FGFR-IN-26 is an orally effective FGFR inhibitor. |
|
V69471 | FGFR1 inhibitor-2 | 2410612-08-5 | FGFR1 inhibitor-2 is an FGFR1 inhibitor (IC50 is 4.55 μM in MDA-MB-231 cells). |
|
V135919 | FGFR3-IN-11 | FGFR3-IN-11 is a fibroblast growth factor receptor 3 (FGFR3) inhibitor with a Ka value of 4.8 μM. | |
|
V69478 | FGFR3-IN-6 | 2833703-72-1 | FGFR3-IN-6 is a potent selective inhibitor of FGFR3 with IC50 of less than 350 nM. |
|
V69479 | FGFR3-IN-7 | 2833703-79-8 | FGFR3-IN-7 is a potent selective inhibitor of FGFR3 with IC50 of less than 350 nM. |
|
V88045 | FGFR3-IN-9 | 2446523-17-5 | FGFR3-IN-9 (example27) is a selective FGFR3 inhibitor. |
|
V21016 | FGFR4-IN-1 | 1708971-72-5 | FGFR4-IN-1 is a potent FGFR4 inhibitor (antagonist) with IC50 of 0.7 nM. |
|
V88034 | FGFR4-IN-20 | FGFR4-IN-20 (comp 11) is an orally active and selective FGFR4 inhibitor with IC50s of 19 and 36 nM for Huh7 cell and FGFR4 enzyme inhibition. | |
|
V105231 | FGFR4-IN-22 | 2922812-74-4 | FGFR4-IN-22 (Compound 10f) is a potent inhibitor of FGFR4 with IC50 of 5.4 nM. |
|
V69476 | FGFR4-IN-5 | 1628793-01-0 | FGFR4-IN-5 is a potent and specific covalent FGFR4 inhibitor (antagonist) with IC50 of 6.5 nM. |
|
V0615 | FIIN-2 | 1633044-56-0 | FIIN-2 (FIIN 2; FIIN2) is a novel irreversible/covalent pan-FGFR inhibitor with potential anticancer activity. |
|
V3131 | H3B-6527 | 1702259-66-2 | H3B-6527 is a potent, highly selective, orally bioavailable, covalent FGFR4 inhibitor with IC50 value of ~1.2 nM. |
|
V137629 | HuGAL-F2 | HuGAL-F2 is a human antibody expressed in CHO cells that targets FGF2. |